Arix Bioscience Aktie
WKN DE: A2DL9L / ISIN: GB00BD045071
| 03.11.2023 17:30:11 | 
PDMR Notification & Director Shareholding
| 
Arix Bioscience PLC (ARIX)
 Arix Bioscience plc PDMR Notification & Director Shareholding Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 40,000 Ordinary shares of 0.001 pence each in the Company (“Shares”) on 3rd November 2023 at a price of £1.15 per share. 
 For further information please contact:  Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ISIN: | GB00BD045071 | 
| Category Code: | DSH | 
| TIDM: | ARIX | 
| LEI Code: | 213800OVT3AHQCXNIX43 | 
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State | 
| Sequence No.: | 282725 | 
| EQS News ID: | 1765125 | 
| End of Announcement | EQS News Service | 
|  | 
 Der finanzen.at Ratgeber für Aktien!
						
						
						
							
								Der finanzen.at Ratgeber für Aktien!
							
							Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Arix Bioscience PLC Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. | 
 
									 
									 
								